New York state opens antitrust probe of Mylan's EpiPen

September 6, 2016

New York state has launched an antitrust probe into Mylan's sale of the EpiPen anti-allergy injector to local school systems, New York's attorney general announced Tuesday.

A preliminary review by the New York office concluded that Mylan may have inserted anticompetitive terms into EpiPen sales contracts with local school systems, said Attorney General Eric Schneiderman.

"No child's life should be put at risk because a parent, school, or healthcare provider cannot afford a simple, life-saving device because of a drug-maker's anti-competitive practices," Schneiderman said.

The probe comes as Mylan faces criticism from Democratic presidential candidate Hillary Clinton, among others, after instituting a five-fold increase in the price of the life-saving epinephrine injectors over a decade.

A Mylan spokeswoman said the drugmaker's "EpiPen4Schools" program has provided more than 700,000 free auto-injectors to more than 65,000 schools in the US and that the program "continues to adhere to all applicable laws and regulations."

The drugmaker previously offered to sell schools additional injectors beyond those provided for free under the program, but that "such restriction no longer remains," the Mylan spokeswoman said.

Since coming under fire for higher prices last month, Mylan has announced plans to offer a generic version of EpiPen and to expand patient assistance programs.

Democratic Senator Amy Klobuchar, whose daughter relies on EpiPen, has called on the Federal Trade Commission to launch an anti-trust investigation against the company, which has a near-monopoly in the market.

Mylan shares rose 0.8 percent to $40.29 in afternoon trade.

Explore further: Price rise for anti-allergy EpiPen sparks furor

Related Stories

Price rise for anti-allergy EpiPen sparks furor

August 23, 2016
A five-fold price hike for EpiPen, which allergy sufferers use to counteract life-threatening reactions, has made Mylan the newest drugmaker to come under attack in the United States for profiteering.

Top US medical group blasts EpiPen's 'exorbitant' costs

August 24, 2016
The American Medical Association urged the maker of the EpiPen, a life-saving device that counteracts severe allergies, to drop its price Wednesday as public outrage mounted over a soaring cost hike.

Mylan boosts EpiPen patient programs, doesn't budge on price

August 25, 2016
Mylan is bulking up programs that help patients pay for its EpiPen emergency allergy treatment after weathering heated criticism about an average cost that has soared over the past decade.

Mylan launching cheaper, generic version of EpiPen

August 29, 2016
The maker of EpiPens will start selling a cheaper, generic version of the emergency allergy shots as the furor over repeated U.S. price hikes continues—and looming competition threatens its near-monopoly.

Pediatric allergist discusses EpiPen controversy

August 26, 2016
Members of Congress are calling for an investigation into the EpiPen maker Mylan. The pharmaceutical company has increased the price of EpiPens, from about $100 in 2008 to more than $500 today.

Clinton offers plan to prevent 'excessive' drug price hikes

September 2, 2016
Following the public outcry over steep increases in price for an emergency allergy treatment, Hillary Clinton is pledging to better protect patients from such costs.

Recommended for you

Shortcut strategy for screening compounds with clinical potentials for drug development

December 4, 2018
Developing a new drug often takes years and costs hundreds of millions of dollars. A shortcut has now been reported in a study led by City University of Hong Kong (CityU), which can potentially reduce the time and costs of ...

Drug wholesalers drove fentanyl's deadly rise, report concludes

December 4, 2018
Fentanyl, a powerful synthetic opioid implicated in nearly 29,000 overdose deaths in the United States last year, most likely spread because of heroin and prescription pill shortages, and also because it was cheaper for drug ...

Global review reports on administration of children's antibiotics

December 4, 2018
Researchers analyzing the sales of oral antibiotics for children in 70 high- and middle-income countries found that consumption varies widely from country to country with little correlation between countries' wealth and the ...

Opioid prescriptions from dentists linked to youth addiction risk

December 3, 2018
Teens and young adults who receive their initial opioid prescriptions from their dentists or oral surgeons are at increased risk for opioid addiction in the following year, a study from the Stanford University School of Medicine ...

Rise in meth and opioid use during pregnancy

November 29, 2018
Amphetamine and opioid use in pregnancy increased substantially over the last decade in the United States, a new Michigan Medicine-led study finds. And a disproportionate rise occurred in rural counties.

Mouse model aids study of immunomodulation

November 19, 2018
Because mice do not respond to immunomodulatory drugs (IMiDs), preclinical therapeutic and safety studies of the effects of IMiDs have not been possible in existing types of mice. This has led to an inability to accurately ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.